These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4626589)

  • 41. Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.
    Decker DG; Malkasian GD; Mussey E; Johnson CE
    Am J Obstet Gynecol; 1967 Mar; 97(5):656-65. PubMed ID: 4959953
    [No Abstract]   [Full Text] [Related]  

  • 42. [Incorporation of H3-thymidine into the DNA of cells of surviving slices of transplantable tumors, sensitive and resistant to sarcolysine].
    Merkulov MF; Shelaputina ZF; Iavorskaia NP; Leskova SG
    Farmakol Toksikol; 1970; 33(6):715-23. PubMed ID: 5518494
    [No Abstract]   [Full Text] [Related]  

  • 43. A controlled clinical trial with the cytostatic agent thyminalkylamine and its fluorinated derivative on advanced ovarian tumours.
    Dvorák O; Elis J; Perlík F; Kvícalová M; Jandová A; Skoda V; Kafka V
    Neoplasma; 1971; 18(4):365-9. PubMed ID: 5568931
    [No Abstract]   [Full Text] [Related]  

  • 44. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative study of the effect of different doses of sarcolysin on the utilization of thymidine-H3 by the cells of sensitive and resistant tumors (in vitro)].
    Kas'ianenko VV
    Farmakol Toksikol; 1968; 31(3):350-4. PubMed ID: 5698118
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antineoplastic polychemotherapy in thoracic pathology].
    Mannes P; Derriks R; Moens R; Heynen E
    Poumon Coeur; 1968; 24(1):83-91. PubMed ID: 4968018
    [No Abstract]   [Full Text] [Related]  

  • 47. In vivo studies of DNA synthesis in human normal and tumor cells.
    Hoffman J; Post J
    Cancer Res; 1967 May; 27(5):898-902. PubMed ID: 6067326
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antineoplastic activity of new preparations from the chlorethylamine group not affecting hemopoiesis].
    Vasil'eva LS; D'iachkovskaia RF; Shuppe NG; Parkhomenko II; Surkova NI
    Izv Akad Nauk SSSR Biol; 1970; 3():459-63. PubMed ID: 5491977
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chemotherapy of breast cancer].
    Sakai K
    Geka Chiryo; 1969 Aug; 21(2):207-18. PubMed ID: 4982958
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of tissue culture in predictive testing of drug sensitivity in human ovarian cancer. Correlation between in vitro results and the response in vivo.
    Tropé C; Sigurdsson K
    Neoplasma; 1982; 29(3):309-14. PubMed ID: 7133226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ultrastructural changes in ovarian tumor cancer cells under the influence of preoperative chemotherapy].
    Ogorodnikova IS; Zubkova TV; Gaĭrabed'iants NG
    Arkh Patol; 1976; 38(2):46-51. PubMed ID: 818986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
    Gerçel-Taylor C; Ackermann MA; Taylor DD
    Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of 5-fluorouracil on various melanoma cell metabolisms. Its use for assessing the cold thymidine pool.
    Vercammen-Grandjean AF; Arnould R; Libert A; Lejeune FJ
    Anticancer Res; 1982; 2(3):133-40. PubMed ID: 7125600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alternative routes of thymidylate biosynthesis in mouse tumors with different sensitivity to 5-fluorouracil].
    Meĭren DV; Belousova AK
    Biokhimiia; 1971; 36(6):1210-6. PubMed ID: 5168352
    [No Abstract]   [Full Text] [Related]  

  • 55. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
    Chernyĭ VA
    Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of certain nitrogen mustards upon the progression of cultured H.Ep. no. 2 cells through the cell cycle.
    Wheeler GP; Bowdon BJ; Adamson DJ; Vail MH
    Cancer Res; 1970 Jan; 30(1):100-11. PubMed ID: 5441070
    [No Abstract]   [Full Text] [Related]  

  • 57. The need for additional alkylating agents.
    Connors TA
    Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
    Wilson AP; Neal FE
    Br J Cancer; 1981 Aug; 44(2):189-200. PubMed ID: 6791675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chromosome aberrations in cells of a thiophosphamide-resistant tumor arising during a single treatment with alkylating preparations and x-rays].
    Voĭtovitskiĭ VK; Edygenova AK; Kabiev OK
    Tsitologiia; 1971 Oct; 13(10):1272-9. PubMed ID: 5002495
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effect of sarcolysine on utilization of H3-thymidine by cells of transplantable tumors in vitro].
    Kas'ianenko VV
    Vopr Onkol; 1968; 14(1):51-5. PubMed ID: 5660341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.